Clinical Trials · NCT04166058

Long-term Safety of Linaclotide in Pediatric Participants With FC or IBS-C

Name: Long-term Safety of Linaclotide in Pediatric Participants With FC or IBS-C
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 3Linaclotide

Phase: Phase 3
Recruitment status: Completed
Sponsor: AbbVie
Enrollment: 381
Start date: Nov 2019
Locations: 72 sites, 4 countries
Primary endpoint: Number of Participants With Treatment-Emergent Adverse Events (TEAEs).

View Linaclotide compound reference